Search | IOVS | ARVO Journals

Showing 1 – 20 of 90

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2021

Expression of immune checkpoint LAG3 is associated with high risk uveal melanoma

Zahra Souri; Gre Luyten; Martine J Jager

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):37. doi:

ARVO Annual Meeting Abstract June 2021

Melanocytes, Inflammation and Responses in the Human Choroidal Microenvironment

Michele C Madigan; Chieh-Lin Wu; Martine J Jager; R. Max Conway; Riccardo Carlo Natoli; V. Adrian Cioanca

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2840. doi:

Anatomy and Pathology/Oncology April 2021

Targeting the YAP/TAZ Pathway in Uveal and Conjunctival Melanoma With Verteporfin

PDF

Niels J. Brouwer; Eleni K. Konstantinou; Evangelos S. Gragoudas; Marina Marinkovic; Gregorius P. M. Luyten; Ivana K. Kim; Martine J. Jager; Demetrios G. Vavvas
TAGS: bap1 gene, cell growth, cell lines, genes, malignant melanoma of conjunctiva, mutation, neoplasms, uvea, verteporfin, proteins
Invest. Ophthalmol. Vis. Sci.. 2021; 62(4):3. doi: https://doi.org/10.1167/iovs.62.4.3

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2020

Targeting HSP: Immune Tolerance to HSP60 Attenuates Neurodegeneration in Glaucoma

Shuhong Jiang; Eric F. Thee; Elisa Arlotti; Kin-Sang Cho; Karen Chang; Li Pan; Jing Tang; Martine J Jager; Dongfeng Chen

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):649. doi:

Anatomy and Pathology/Oncology March 2020

Prognostic Factors Five Years After Enucleation for Uveal Melanoma

PDF

Mehmet Dogrusöz; Niels J. Brouwer; Stefan J. R. de Geus; Long V. Ly; Stefan Böhringer; Sjoerd G. van Duinen; Wilma G. M. Kroes; Pieter A. van der Velden; Geert W. Haasnoot; Marina Marinkovic; Gregorius P. M. Luyten; Tero T. Kivelä; Martine J. Jager
TAGS: cellular enucleation, enucleation procedure, intraocular melanoma, neoplasms, prognostic factors, neoplasm metastasis, cohort studies
Invest. Ophthalmol. Vis. Sci.. 2020; 61(3):31. doi: https://doi.org/10.1167/iovs.61.3.31

Anatomy and Pathology/Oncology November 2019

Aqueous Humor Biomarkers Identify Three Prognostic Groups in Uveal Melanoma

PDF

Annemijn P. A. Wierenga; Jinfeng Cao; Henk Mouthaan; Christiaan van Weeghel; Robert M. Verdijk; Sjoerd G. van Duinen; Wilma G. M. Kroes; Mehmet Dogrusöz; Marina Marinkovic; Sjoerd S. H. van der Burg; Gregorius P. M. Luyten; Martine J. Jager
TAGS: aqueous humor, biological markers, biopsy, cytokine, intraocular melanoma, neoplasms, patient prognosis, histopathology tests, eye
Invest. Ophthalmol. Vis. Sci.. 2019; 60(14):4740-4747. doi: https://doi.org/10.1167/iovs.19-28309

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2019

Retinal oximetry in choroidal melanoma and nevi

Niels J Brouwer; Marina Marinkovic; Jaco C Bleeker; Einar Stefánsson; Gregorius P.M. Luyten; Martine J Jager

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):961. doi:

ARVO Annual Meeting Abstract July 2019

Macrophages and eye diseases in the elderly.

Martine J Jager

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3266. doi:

ARVO Annual Meeting Abstract July 2019

Inflammatory profile of human choroidal nevi

Melissa Therese Wegkamp; Martine J Jager; Madeleine Vader; Michele C Madigan

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):736. doi:

ARVO Annual Meeting Abstract July 2019

Influence of GNAQ or GNA11 mutations on HLA expression in Uveal Melanoma

Christiaan Weeghel; Annemijn Philine Annette Wierenga; Mieke Versluis; Gregorius P.M. Luyten; Martine J Jager

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):739. doi:

ARVO Annual Meeting Abstract July 2019

Soluble HLA in the aqueous humour as risk factor or a marker of inflammation in uveal melanoma

Annemijn Philine Annette Wierenga; Gulcin Gezgin; Els van Beelen; Michael Eikmans; Mieke Versluis; Robert M. Verdijk; Sjoerd van Duinen; Marina Marinkovic; Gregorius P.M. Luyten; Martine J Jager

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):740. doi:

ARVO Annual Meeting Abstract July 2019

Regulation of PD-L1 in uveal melanoma

Zahra Souri; Annemijn Philine Annette Wierenga; Marijke Spruyt-Gerritse; Michael Eikmans; Martine J Jager

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):741. doi:

ARVO Annual Meeting Abstract July 2019

Clinical, tumour, and family characteristics of uveal melanoma patients referred for analysis of potential underlying BAP1 -tumour predisposition syndrome

Cindy Chau; Katya Afanasieva; Martine J Jager; Gregorius P.M. Luyten

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):759. doi:

Anatomy and Pathology/Oncology July 2019

Chemokine Receptor Expression Pattern Correlates to Progression of Conjunctival Melanocytic Lesions

PDF

Jolique A. van Ipenburg; Nadine E. de Waard; Nicole C. Naus; Martine J. Jager; Dion Paridaens; Robert M. Verdijk
TAGS: atypical, chemokine receptors, chemokines, conjunctiva, cxcr4 receptors, melanoma, nevus, neoplasm metastasis, immune reconstitution inflammatory syndrome, insulin receptor substrate proteins
Invest. Ophthalmol. Vis. Sci.. 2019; 60(8):2950-2957. doi: https://doi.org/10.1167/iovs.19-27162

Perspective January 2019

Proceedings of the Association for Research in Vision and Ophthalmology and Champalimaud Foundation Ocular Oncogenesis and Oncology Conference

PDF

Justine R. Smith; Jacob Pe'er; Rubens N. Belfort; Fatima Cardoso; Richard D. Carvajal; Carlos Carvalho; Sarah E. Coupland; Laurence Desjardins; Jasmine H. Francis; Brenda L. Gallie; Dan S. Gombos; Hans E. Grossniklaus; Steffen Heegaard; Martine J. Jager; Swathi Kaliki; Bruce R. Ksander; Markus Maeurer; Eduardo Moreno; Jose S. Pulido; Bettina Ryll; Arun D. Singh; Junyang Zhao; António Parreira; David J. Wilson; Joan M. O'Brien
TAGS: carcinogenesis, medical oncology, ophthalmology, tumorigenesis, vision research, intraocular melanoma, neoplasms, cancer, eye cancer
Trans. Vis. Sci. Tech.. 2019; 8(1):9. doi: https://doi.org/10.1167/tvst.8.1.9

ARVO Annual Meeting Abstract July 2018

Adjuvant brachytherapy with strontium-90 or ruthenium-106 in conjunctival melanoma

Niels J Brouwer; Marina Marinkovic; Femke P Peters; Maarten C Hulshof; Bradley R Pieters; Rob J W de Keizer; Nanda Horeweg; Mirjam S Laman; Jaco C Bleeker; Sjoerd G van Duinen; Martine J. Jager; Carien L Creutzberg; Gregorius P M Luyten

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3627. doi:

ARVO Annual Meeting Abstract July 2018

Uveal Melanoma Metastatic Rate is Relative to Stochastic Mutation Rate and Type of Mutation

Eszter Szalai; Yi Jiang; Natasha M. van Poppelen; Martine J. Jager; Annelies de Klein; Emine Kilic; Hans Grossniklaus

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3633. doi:

ARVO Annual Meeting Abstract July 2018

Uveal consequences of CTLA-4 and PD-1 inhibition

Martine J. Jager

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4409. doi:

ARVO Annual Meeting Abstract July 2018

Immune tolerance to HSP60 attenuates neurodegeneration in a mouse model of glaucoma

Eric F. Thee; Kin-Sang Cho; Martine J. Jager; Dong Feng Chen

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):6142. doi:

Anatomy and Pathology/Oncology February 2018

HLA Class I Antigen Expression in Conjunctival Melanoma Is Not Associated With PD-L1/PD-1 Status

PDF

Jinfeng Cao; Niels J. Brouwer; Ekaterina S. Jordanova; Marina Marinkovic; Sjoerd G. van Duinen; Nadine E. de Waard; Bruce R. Ksander; Arend Mulder; Frans H. J. Claas; Mirjam H. M. Heemskerk; Martine J. Jager
TAGS: human leukocyte antigens, programmed cell death 1 ligand 1, malignant melanoma of conjunctiva, human leukocyte antigen class i, cell lines
Invest. Ophthalmol. Vis. Sci.. 2018; 59(2):1005-1015. doi: https://doi.org/10.1167/iovs.17-23209

Includes: Supplemental Content

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Expression of immune checkpoint LAG3 is associated with high risk uveal melanoma

Melanocytes, Inflammation and Responses in the Human Choroidal Microenvironment

Targeting the YAP/TAZ Pathway in Uveal and Conjunctival Melanoma With Verteporfin

Targeting HSP: Immune Tolerance to HSP60 Attenuates Neurodegeneration in Glaucoma

Prognostic Factors Five Years After Enucleation for Uveal Melanoma

Aqueous Humor Biomarkers Identify Three Prognostic Groups in Uveal Melanoma

Retinal oximetry in choroidal melanoma and nevi

Macrophages and eye diseases in the elderly.

Inflammatory profile of human choroidal nevi

Influence of GNAQ or GNA11 mutations on HLA expression in Uveal Melanoma

Soluble HLA in the aqueous humour as risk factor or a marker of inflammation in uveal melanoma

Regulation of PD-L1 in uveal melanoma

Clinical, tumour, and family characteristics of uveal melanoma patients referred for analysis of potential underlying BAP1 -tumour predisposition syndrome

Chemokine Receptor Expression Pattern Correlates to Progression of Conjunctival Melanocytic Lesions

Proceedings of the Association for Research in Vision and Ophthalmology and Champalimaud Foundation Ocular Oncogenesis and Oncology Conference

Adjuvant brachytherapy with strontium-90 or ruthenium-106 in conjunctival melanoma

Uveal Melanoma Metastatic Rate is Relative to Stochastic Mutation Rate and Type of Mutation

Uveal consequences of CTLA-4 and PD-1 inhibition

Immune tolerance to HSP60 attenuates neurodegeneration in a mouse model of glaucoma

HLA Class I Antigen Expression in Conjunctival Melanoma Is Not Associated With PD-L1/PD-1 Status

To View More...

You must be signed into an individual account to use this feature.